SightLife Surgical acquires Kamra inlay

17:02 EST 8 Mar 2018 | Healio

SightLife Surgical and AcuFocus today announced the companies have agreed to terms for SightLife to acquire the Kamra inlay from AcuFocus.
The Kamra is the first FDA-approved inlay for the surgical correction of presbyopia.
“As we’ve monitored the progress made in the corneal inlay market, we have been impressed with the AcuFocus team and their Kamra inlay technology,” Monty Montoya, CEO of SightLife Surgical, said in a press release on the acquisition. “We look forward to adding this proven technology to SightLife Surgical and carrying forward the development of this

Original Article: SightLife Surgical acquires Kamra inlay


More From BioPortfolio on "SightLife Surgical acquires Kamra inlay"

Quick Search


Relevant Topics

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...